Top-20 Pharmaceutical Company Adopts Cloud Biometrics Solution to Improve Global Clinical Trial Oversight and Outcomes

Top-20 Pharmaceutical Company Adopts Cloud Biometrics Solution to Improve Global Clinical Trial Oversight and Outcomes

Author Name


Accelerating Digital Transformation and Innovation in Patient Health

New Jersey, USA – MaxisIT, a leading provider of platform technologies for clinical research, including clinical trial oversight, today announced the award of a multi-year agreement by a top-20 pharmaceutical company in the USA. The sponsor will deploy MaxisIT’s Cloud-based platform as a strategic part of its digital transformation initiative. The MaxisIT Clinical Trial Oversight System (CTOS) will replace outdated clinical data and biometrics systems. The deployment includes MaxisIT’s Data Management Workbench (DMW), Statistical Computing Environment (SCE), and Metadata Repository (MDR) offering a single-source-of-truth for clinical, operational, and pre-clinical data. Use of the comprehensive data and analytics platform will help improve the performance of clinical trials, improve decision making and reduce costs of the company’s clinical development programs by automating the data ingestion to analytics process with 50+ vendor integrations, including digital and real-world data sources.

Clinical trials have become even more complex with the greater adoption of decentralized trials, adaptive trial designs, and new Risk-Based Quality Monitoring guidance. Innovative companies are reaching beyond traditional methods and adopting a total oversight approach supported by holistic data strategy and a focus on patient centricity. In many cases, new trial designs require patients to adapt to wearable devices, in-home procedures, and telemedicine. MaxisIT’s CTOS platform unlocks the value of clinical data with trial oversight, quality management, exploration, and regulatory compliance, which reduce delays and costs across clinical development processes.

By using MaxisIT’s CTOS, biometrics and clinical teams can process the variety and volume of data faster in an automated fashion. The reduced cycle time and increased control ensure that pharmaceutical companies meet deadlines and improve data quality. Faster access to clean data allows clinical teams to focus on planning, monitoring, deriving insights and analysis in near-real-time. MaxisIT delivers Total Oversight.
“As the variety, volume, and complexity of data in clinical trials have increased clinical operations, teams, data managers, and IT groups are struggling to integrate all of this data in a way that provides value to their organizations,” said Moulik Shah, CEO, MaxisIT. “Innovative companies such as this are driving digital innovation with purpose-built platforms that support the entire clinical data value chain in a self-service manner that is delivered via a secured cloud. MaxisIT’s CTOS is successfully delivering value at a faster return on investment while ensuring regulatory compliance.”

MaxisIT’s CTOS platform has a comprehensive set of out-of-the-box integrations to most industry-accepted eClinical apps, operational data sources, and CROs’ systems. It leverages built-in intelligence that drives automation and reduces manual error-prone steps in data management, programming, and analytical processes. Overall, it offers greater levels of standardization, reusability, and traceability among siloed clinical data, while truly empowering clinical development teams across functions.

Additional Resources
MaxisIT Integrated Clinical Development Platform
MaxisIT Cloud Services Video
MaxisIT Twitter: @MaxisITInc
About MaxisIT
MaxisIT empowers the Biopharmaceutical industry with Integrated Computing, Self-service Analytics, and Enterprise Externalization via its Cloud-based Integrated Clinical Development Platform. For more information about MaxisIT, visit


Fill out the form or email to Speak with an Expert

    Subscribe to blog

    Upcoming News